The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Corcept Therapeutics Inc’s stock clocked out at $23.97, down -2.24% from its previous closing price of $24.52. In other words, the price has decreased by -$2.24 from its previous closing price. On the day, 1.23 million shares were traded. CORT stock price reached its highest trading level at $24.58 during the session, while it also had its lowest trading level at $23.02.
Ratios:
To gain a deeper understanding of CORT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.01. For the most recent quarter (mrq), Quick Ratio is recorded 5.10 and its Current Ratio is at 5.18. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 02 ’24 when Lyon Joseph Douglas sold 10,830 shares for $26.00 per share. The transaction valued at 281,580 led to the insider holds 7,314 shares of the business.
Swisher Daniel N JR sold 2,200 shares of CORT for $50,798 on May 01 ’24. The Director now owns 0 shares after completing the transaction at $23.09 per share. On Apr 04 ’24, another insider, Lyon Joseph Douglas, who serves as the insider of the company, sold 5,443 shares for $26.00 each. As a result, the insider received 141,524 and left with 7,314 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 2552828928 and an Enterprise Value of 2084881792. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.59, and their Forward P/E ratio for the next fiscal year is 18.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.77 while its Price-to-Book (P/B) ratio in mrq is 4.55. Its current Enterprise Value per Revenue stands at 3.982 whereas that against EBITDA is 16.978.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $34.28, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is 0.23%, while the 200-Day Moving Average is calculated to be -9.88%.
Shares Statistics:
It appears that CORT traded 1.11M shares on average per day over the past three months and 1701390 shares per day over the past ten days. A total of 103.41M shares are outstanding, with a floating share count of 89.71M. Insiders hold about 13.84% of the company’s shares, while institutions hold 80.91% stake in the company. Shares short for CORT as of 1713139200 were 21122317 with a Short Ratio of 19.08, compared to 1710460800 on 20215345. Therefore, it implies a Short% of Shares Outstanding of 21122317 and a Short% of Float of 28.67.
